Type 1 diabetes: open trials in Saudi Arabia

6 open trials have a site in Saudi Arabia. Registry data; only the trial team decides who can take part.

NCT07038473
Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
Trial Treatment · Sanofi
Imam Abdulrahman Bin Faisal University - Site Number: 05, Dammam · King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01, Jeddah · King Fahd Medical City - Site Number: 03, Riyadh · King Faisal Specialist Hospital & Research Centre - Site Number: 02, Riyadh
Registry updated 2026-10-23
NCT04786262
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated
King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology, Riyadh · King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology, Riyadh
Registry updated 2026-09-01
NCT07614412
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
Trial Treatment · Phase 2 · Ministry of Health, Saudi Arabia
Ministry of Health Medical City, Riyadh
Registry updated 2026-05-29
NCT06832410
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated
King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology, Riyadh · King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology, Riyadh
Registry updated 2026-03-23
NCT06922656
Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
Trial Treatment · Phase 4 · Dasman Diabetes Institute
Diabetes and Endocrine Treatment Center, Prince Sultan Military Medical City. Kidney & Pancreas Health Centre, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Alfaisal Univeristy, Riyadh, Kingdom of Saudi Arabia, Riyadh
Registry updated 2025-08-29
NCT06513247
Screening Program for Type 1 Diabetes in a High-Risk Population
Research · King Saud University
The University Diabetes Centre at King Saud University Medial CIty, Riyadh
Registry updated 2024-07-22

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Type 1 diabetes: open trials in Saudi Arabia

Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?

Screening Program for Type 1 Diabetes in a High-Risk Population